CONMED Corporation (CNMD)
Profitability ratios
Return on sales
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
|---|---|---|---|---|---|
| Gross profit margin | 56.08% | 54.33% | 54.64% | 56.21% | 53.37% |
| Operating profit margin | 15.33% | 10.51% | 6.70% | 3.74% | -3.13% |
| Pretax margin | 12.47% | 6.49% | -6.78% | 7.23% | 0.19% |
| Net profit margin | 10.13% | 5.18% | -7.71% | 6.19% | 1.10% |
CONMED Corporation has shown an improvement in its profitability ratios over the years based on the provided data.
1. Gross Profit Margin:
- The gross profit margin increased from 53.37% in 2020 to 56.08% in 2024. This indicates that the company's efficiency in producing goods has improved, resulting in higher profitability from sales.
2. Operating Profit Margin:
- CONMED Corporation improved its operating profit margin significantly from -3.13% in 2020 to 15.33% in 2024. This implies that the company has effectively controlled its operating expenses and is generating healthier profits from its core operations.
3. Pretax Margin:
- The pretax margin fluctuated but generally improved from 0.19% in 2020 to 12.47% in 2024. Despite some volatility, the company managed to increase its profitability before accounting for taxes.
4. Net Profit Margin:
- The net profit margin improved from 1.10% in 2020 to 10.13% in 2024. This indicates that CONMED Corporation has been successful in managing not only its operating expenses but also its interest payments and taxes, leading to higher net profits relative to its sales.
Overall, CONMED Corporation has demonstrated a positive trend in its profitability ratios, showcasing improved efficiency in operations, prudent cost management, and enhanced profitability over the years.
Return on investment
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | 8.69% | 5.69% | 3.05% | 2.14% | -1.54% |
| Return on assets (ROA) | 5.74% | 2.80% | -3.51% | 3.54% | 0.54% |
| Return on total capital | 20.81% | 16.91% | -5.63% | 13.83% | 8.65% |
| Return on equity (ROE) | 13.76% | 7.73% | -10.81% | 7.96% | 1.34% |
CONMED Corporation's profitability has shown fluctuations over the years as depicted by the profitability ratios.
1. Operating return on assets (Operating ROA) has been steadily increasing from -1.54% in December 2020 to 8.69% in December 2024. This indicates that the company has been able to generate more operating income from its assets over time.
2. Return on assets (ROA) improved significantly from 0.54% in December 2020 to 5.74% in December 2024. Despite a dip in 2022, the company managed to recover and achieve higher returns on its total assets.
3. Return on total capital started at 8.65% in December 2020, had a negative value in 2022 at -5.63%, and then increased to 20.81% in December 2024. This indicates that the company has been effectively utilizing its total capital to generate higher returns in recent years.
4. Return on equity (ROE) fluctuated over the period, ranging from -10.81% in December 2022 to 13.76% in December 2024. The company's ability to deliver value to its shareholders in terms of profitability has shown improvement over the years.
Overall, CONMED Corporation has shown a positive trend in profitability ratios, with improvements in ROA, Operating ROA, Return on total capital, and ROE. These improvements indicate that the company has been successful in optimizing its assets and capital to drive profitability and create value for its shareholders.